Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis: Correlation with its paired bone marrow and standard disease markers Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Bone Marrow
  • Brain Neoplasms
  • Neoplastic Cells, Circulating
  • Neuroblastoma

abstract

  • BM monitoring should continue to be an integral part of disease follow-up for patients with Stage 4 NB. PB monitoring to complement tumor surveillance in the BM can be informative.

publication date

  • November 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20660

PubMed ID

  • 15484213

Additional Document Info

start page

  • 2303

end page

  • 8

volume

  • 101

number

  • 10